About Deerfield
Deerfield is a Financial Services company based in New York (United States). Healthcare ecosystem is supported through investment and innovation by Deerfield. It operates on a Commission-Based and Professional Services model in Financial Services and Healthcare sectors. Deerfield has completed 5 acquisitions, including Ablexis, DC Fabricators and Melinta Therapeutics. Deerfield offers products and services including Investment Funding, Healthcare Intelligence, and Philanthropy Initiatives. Its focus areas include Investment, Venture Capital, Technology and Digital Health. Its legal entity is Deerfield Management.
Company details
Deerfield Management is engaged in advancing healthcare through investment, intelligence, and philanthropy. The company is focused on supporting companies across the healthcare ecosystem with flexible funding models. Innovation is driven by leveraging AI, data, and market research to push healthcare technology forward. Additionally, healthcare initiatives are promoted through a New York City-based non-profit entity. Strategic partnerships and company-building efforts, such as Deerfield Discovery and Development (3DC), are utilized to foster progress in the sector. Portfolio companies are provided access to in-building lab spaces and state-of-the-art equipment to test scientific ideas.
- Headquarters New York, United States
- SectorsFinancial ServicesHealthcare
- Phone•••• ••••
- Website deerfield.com
- Legal Name Deerfield Management
- Investments & AcquisitionsAblexis
& 4 more
Products & Services of Deerfield
Deerfield offers a comprehensive portfolio of products and services, including Investment Funding, Healthcare Intelligence, and Philanthropy Initiatives.
Funding is provided to healthcare companies for growth.
Healthcare innovation is driven by AI and data.
Healthcare initiatives are supported through non-profit efforts.
People of Deerfield
40 people are tracked at Deerfield (23 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
David Clark | Partner & General Counsel | Leadership |
Bryan Sendrowski | Partner & Chief Financial Officer | Leadership |
Stephen Anastos | Managing Director | Leadership |
Adam Grossman | Partner | Leadership |
Sam Galindo | Director, Innovation Alliances, Deerfield Discovery And Development (3dc) | Leadership |
David Neustaedter | Venture Partner | Leadership |
Abraham Kometz | Partner | Leadership |
Abdul Khan | Director, Biologics, Deerfield Discovery & Development | Leadership |
Andrew ElBardissi | Partner | Leadership |
Cameron Wheeler | Partner | Leadership |
Brian Bizoza | Partner | Leadership |
James E. Flynn | Managing Partner | Leadership |
Alexis Cazé | Partner & Managing Director | Leadership |
Avi Kometz | Partner | Leadership |
Dr. Mussaad M. al-Razouki | Operating Partner | Leadership |
Brian Raudenbush | Senior Director, Deerfield Discovery & Development | Leadership |
Ivo Lorenz | Head Of Biologics & Research Partnerships Lead, Deerfield Discovery And Development (3dc) | Leadership |
Marissa Carnevale | Director Of Talent Acquisition, Portfolio Company Operations | Leadership |
Angelo Stornello | Chief Technology Officer | Leadership |
Anna Kim | Director, Learning & Development | Leadership |
20 more people are available in the full profile.
Complete people profiles for Deerfield
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Deerfield
Deerfield has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Ablexis, DC Fabricators and Melinta Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Next-generation gene sequencing and multi-omics technologies are provided. | singulargenomics.com | San Diego, United States | 2016 | Dec 2024 | •••• | |
Developer of bacterial ribosome-targeting drugs for MDR infections | melinta.com | Morristown, United States | 2000 | Jun 2020 | •••• | |
Transgenic mouse platforms are developed for human antibody discovery. | ablexis.com | San Francisco, United States | 2009 | Jun 2018 | •••• | |
Nitric oxide enhanced medicines for heart failure treatment are developed. | nitromed.com | Lexington, United States | 1992 | Jan 2009 | •••• | |
Shop and office facilities for the defense sector are provided. | dcfab.com | Florence, United States | 1997 | Jul 1999 | •••• |
Complete acquisition details for Deerfield
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Deerfield
5 dated milestones of Deerfield across 25 years, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires DC Fabricators.
- Acquisition Acquires NitoMed.
- Acquisition Acquires Ablexis.
- Acquisition Acquires Melinta Therapeutics.
- Acquisition Acquires Singular Genomics.
Web traffic of Deerfield
Websites that share an audience with Deerfield (deerfield.com).
Websites whose visitors overlap most with Deerfield. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| clavister.com | 71% | 22.8K | #1,002,355 | View details | |
| sybari.com | 57% | 3.1K | View details |
Top companies in Venture Capital Funds
3 companies that operate in the same segment as Deerfield (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Deerfield
Complete news archive for Deerfield
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deerfield
Deerfield is headquartered in New York, United States. It is registered at New York, New York, United States.
Deerfield Management is engaged in advancing healthcare through investment, intelligence, and philanthropy. The company is focused on supporting companies across the healthcare ecosystem with flexible funding models. Innovation is driven by leveraging AI, data, and market research to push healthcare technology forward. Additionally, healthcare initiatives are promoted through a New York City-based non-profit entity. Strategic partnerships and company-building efforts, such as Deerfield Discovery and Development (3DC), are utilized to foster progress in the sector. Portfolio companies are provided access to in-building lab spaces and state-of-the-art equipment to test scientific ideas.
Deerfield offers Investment Funding, Healthcare Intelligence, and Philanthropy Initiatives.
Deerfield has made 5 acquisitions, including Ablexis, DC Fabricators, and Melinta Therapeutics.
Deerfield operates through Deerfield Management.